Longitudinal Monitoring of Pan-Immune–Inflammation Value Forecast Outcomes for Patients with Head and Neck Cancer Treated with Chemoradiotherapy or Radiotherapy: Results from a Large Cohort Study

<b>Background/Objectives</b>: We aim to investigate whether tracking pan-immune–inflammation value (PIV) dynamics during radiotherapy (RT) can inform real-time prognosis in patients with head and neck cancer (HNC). <b>Methods</b>: We retrospectively reviewed the medical records of patients with HNC...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sean Hsiang-Ting Chen, Tsung-You Tsai, Rodney Cheng-En Hsieh, Kai-Ping Chang, Chung-Jan Kang, Yi-An Lu, Pei-Wei Huang, Miao-Fen Chen, Chien-Yu Lin, Shanli Ding, Ngan-Ming Tsang, Wen-Hsin Lu, Wing-Keen Yap, Alex Chia-Hsin Lin
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2026-04-01
Col·lecció:	Biomedicines
Matèries:	pan-immune–inflammation value head and neck cancer radiotherapy biomarker longitudinal monitoring
Accés en línia:	https://www.mdpi.com/2227-9059/14/4/830
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!